End of life prescribing guidance

Similar documents
PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Algorithms for Symptom Management. In End of Life Care

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Care of the Dying Management in Severe Renal Failure

Syringe driver in Palliative Care

Care of the Dying Management in Severe Renal Failure

Renal Palliative Care Last Days of Life

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

SYRINGE DRIVER MEDICATIONS

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Care in the Last Days of Life

Supportive Care. End of Life Phase

Symptom Management Guidelines for End of Life Care

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

Palliative care for heart failure patients. Susan Addie

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Care of dying adults in the last days of life. Improving care at the very end of life.

MND Just in Case kit Information for GPs

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Implementing the recommendation on medication management and symptom control

Conservative Management of Uraemia

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Clatterbridge Centre for Oncology

SCHEDULE 2 THE SERVICES

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

BACKGROUND Measuring renal function :

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

End Stage Liver Disease Regional Audit Casenote Survey

Palliative Prescribing - Pain

Using syringe pumps in palliative care

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Berkshire West Area Prescribing Committee Guidance

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Palliative Care Impact Survey

Treating the symptoms of kidney failure

Morphine and strong opioid information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

The last days of life in hospital and at home

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Opioid Type Pain Killers

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

PALLIATIVE CARE PRESCRIBING

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Regional Renal Training

PALLIATIVE CARE PRESCRIBING

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Syringe Drivers. Back to top

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Strong opioids for palliative care patients

Morphine and other opioids for pain

BJF Acute Pain Team Formulary Group

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Coversheet for Network Site Specific Group Agreed Documentation

Adult Opioid Prescribing Guidelines for Acute or Persistent Pain

BREATHLESSNESS MANAGEMENT

Eastern Health and Social Services Board Palliative Care

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

The Mid Yorkshire Macmillan Specialist Palliative Care Team

Isle of Wight Syringe Driver Compatibility Guidelines

This survey aims to look at individual practice and can be completed by any healthcare professional.

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

PALLIATIVE CARE PRESCRIBING GUIDELINES LANCASHIRE AND SOUTH CUMBRIA PALLIATIVE AND END OF LIFE CARE ADVISORY GROUP 2014

Opioids in Palliative Care

Using strong opiods for pain in palliative care

Planning for the future; A guide to symptom control at end of life in advanced dementia

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Lothian Palliative Care Guidelines POCKET EDITION 2004

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Palliative Care Formulary

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

Dose equivalent of fentanyl patch to oxycontin

General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients

Long Term Care Formulary HCD - 08

Persistent Pain Resources. Educational Slide Set

Analgesia in patients with impaired renal function Formulary Guidance

Palliative care for patients with brain cancer

Pain CONCERN. Medicines for long-term pain. Opioids

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Transcription:

End of life prescribing guidance

Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly encountered in the last days of life, and are designed for adults. Adapted from the Lancashire and South Cumbria Palliative Care Prescribing Guidelines (2014) for use in the Greater Preston and Chorley and South Ribble CCGs the guidance relates to the use of medicines administered via the subcutaneous route, indicated when the oral route is inappropriate for example, persistent nausea, vomiting, malabsorption, dysphagia and unconsciousness. General Principles For people starting treatment who have not previously been given medicines for symptom management, start with the lowest effective dose and titrate as clinically indicated. Regularly reassess, at least daily, the dying person's symptoms during treatment to inform appropriate titration of medicine. Seek specialist palliative care advice if the dying person's symptoms do not improve promptly with treatment or if there are undesirable side effects, such as unwanted sedation. It is the responsibility of the prescribing clinician to prescribe appropriate medication and doses required by each individual patient. Take into consideration individual patient factors e.g. renal function. Doses provided within the document are for guidance only. Discuss any prescribing needs with the dying person, those important to them and the multiprofessional team. When deciding which anticipatory medicines to offer take into account: o the likelihood of specific symptoms occurring o the benefits and harms of prescribing or administering medicines o the benefits and harms of not prescribing or administering medicines o the possible risk of the person suddenly deteriorating (for example, catastrophic haemorrhage or seizures) for which urgent symptom control may be needed o the place of care and the time it would take to obtain medicines. Specialist Palliative Care Team Contact Details St Catherine s hospice 24/7 advice line: 01772 629171 Further references NICE (2015) Care of dying adults in the last days of life Lancashire and South Cumbria Palliative and End of Life Care Advisory Group Prescribing Guidelines 2014

Pain control at the end of life Revised for use in Greater Preston and Chorley and South Ribble CCGs from the Lancashire and Cumbria palliative care guidelines Pain Patient is in pain Patient s pain is controlled Is patient already taking oral morphine? Is patient already taking oral morphine? Yes No Yes No 1. Convert to a Syringe Driver accordingly or seek support from the Palliative Care Team or Pharmacy 1. * Morphine 2.5 5mg sc hourly prn. If three or more doses required within 4 hours seek medical review 2. After 24hrs review medication, if three or more doses required prn then consider a syringe driver over 24hrs 1. To convert a patient from oral morphine to a 24 hour sc infusion of morphine divide the total daily dose of morphine by 2 eg MST 30mg bd orally = Morphine 30mg via sc syringe driver See note below regarding other strong opioids, including patches 2. Prescribe hourly prn dose of morphine which should be 1/6th of 24 hour dose in driver eg Morphine 30mg via the driver will require 5mg Morphine sc prn 1. * Morphine 2.5mg 5mg sc hourly prn. If three or more doses required within 4 hours seek medical review 2. After 24hrs review medication, if three or more doses required prn then consider a syringe driver over 24hrs

Supportive information To convert other strong opioids (e.g. oxycodone or fentanyl) to subcutaneous route contact Palliative Care Team/Pharmacy for further advice and support on conversion ratios. Also see Palliative Care Guidance on opioid dose conversion and fentanyl prescribing notes, see chapter on Opioid Conversions starting on page 20. It is usual practices to leave fentanyl or buprenorphine patches in place If patient has impaired renal function consider reducing doses or alternative opioid.

Terminal restlessness and agitation Terminal restlessness and agitation Present Absent 1. Midazolam 2.5-5mg s/c 4 hourly prn 1. Midazolam 2.5-5mg s/c 4 hourly prn 2. Review the required medication after 24hrs, if three or more prn doses have been required then consider a syringe driver over 24 hrs 2. If three or more doses required prn, consider use of a syringe driver over 24hrs 3. Continue to give prn dosage accordingly Supportive information Maximum dose Midazolam 30mg/24 hours Exclude reversible causes e.g. urinary retention, constipation, pain

Respiratory tract secretions at the end of life Respiratory tract secretions Present Absent 1. Glycopyrronium 0.2mg sc 4hrly. Consider a syringe driver with 0.6-1.2mg over 24 hours 2. Continue to give prn dosage accordingly 1. Glycopyrronium 0.2mg sc 4 hourly prn 2. If two or more doses of prn glycopyrronium required consider a syringe driver sc over 24 hours 3. Increase total 24hr dose to 1.2 mg after 24hrs if symptoms persist Supportive information Consider turning patient Other antisecretory medication include hyoscine butylbromide 20mg sc 4-6hourly or hyoscine hydrobromide 400 micrograms sc 4-6hourly

Nausea and vomiting at the end of life Nausea and vomiting Present Absent 1. Levomepromazine 2.5-5mg s/c 6 hourly prn (max 25mg/24hours) 1. Levomepromazine 2.5-5mg s/c 6 hourly prn 2. Review dosage after 24 hrs. If two or more prn doses given, then consider use of a syringe driver 3. Continue to use Levomepromazine 2.5-5mg s/c prn 6 hourly (max 25mg/24 hours) Supportive information Alternative Antiemetics are: Haloperidol 1mg 2.5mg sc 8 hourly (up to 10mg in a syringe driver over 24 hours) Cyclizine 50mg sc 8 hourly prn max of 100-150mgs over 24 hours

Conversion charts Conversion between oral morphine, oral oxycodone and fentanyl patches Morphine Oxycodone Fentanyl 4 hourly oral MR BD oral MR OD oral 4 hourly oral MR BD oral 3 day patch 5mg 15mg 30mg 2.5mg 10mg 12 microgram 10mg 30mg 60mg 5mg 20mg 25 microgram 15mg 45mg 90mg 10mg 30mg 37 microgram 20mg* 60mg* 120mg* 15mg* 40mg* 50 microgram* 30mg 90mg 180mg 20mg 60mg 75 microgram 40mg 120mg 240mg 25mg 80mg 100 microgram 50mg 150mg 300mg 35mg 100mg 125 microgram 60mg 180mg 360mg 40mg 120mg 150 microgram 70mg 210mg 420mg 45mg 140mg 175 microgram 80mg 240mg 480mg 55mg 160mg 200 microgram 90mg 270mg 540mg 60mg 180mg 225 microgram 100mg 300mg 600mg 65mg 200mg 250 microgram 110mg 330mg 660mg 75mg 220mg 275 microgram 120mg 360mg 720mg 80mg 240mg 300 microgram *Specialist advice should be sought if patients require more than 120 mg morphine (or equivalent) daily. Notes 1. Fentanyl 12 microgram per hour patch is licensed for dose titration between 25-50-75 microgram patches but not as a starting dose. 2. This chart represents BNF recommendations (September 2013). Oral oxycodone is considered to be 1.5 times more potent than oral morphine; transdermal fentanyl is considered 100 times more potent than oral morphine. Please note these figures differ from manufacturers recommendations.

Conversion between weak opioids to oral morphine Drug To obtain equivalent oral morphine dose, multiply by: For example, if the patient is having: Dose in 24h Approximate oral morphine equivalent In 24 hours Dihydrocodeine 1/10 30mg q.d.s 120mg 10mg Codeine 1/10 30mg q.d.s 120mg 10mg Tramadol 1/10 100mg q.d.s 400mg 40mg Conversion from transdermal buprenorphine In these tables transdermal buprenorphine is considered 100 times more potent than oral morphine. Some texts quote transdermal buprenorphine as 75 times more potent. BuTrans lower dose buprenorphine formulation patch designed to deliver 5, 10, or 20 microgram per hour changed every seven days, and approximately equivalent to the doses of morphine listed below: BuTrans 5Microgram/hour 10Microgram/hour 20Microgram/hour Oral Morphine 12mg per 24 hour 24mg per 24 hour 48mg per 24 hour Transtec higher dose buprenorphine formulation patch designed to deliver 35, 52.5 or 70 microgram per hour changed every four days. Transtec 35microgram/hour 52.5microgram/hour 70microgram/hour Oral Morphine 80mg per 24 hour 120mg per 24 hour 160mg per 24hour

Conversion between oral morphine and s/c morphine and s/c diamorphine MST bd (oral morphine) Morphine syringe driver s/c in 24 hours Diamorphine syringe driver s/c in 24 hours 15mg 15mg 10mg 30mg 30mg 20mg 45mg 45mg 30mg 60mg 60mg 40mg 90mg 90mg 60mg 120mg 120mg* 80mg 135mg 135mg* 90mg 150mg 150mg* 100mg 180mg 180mg* 120mg

List of community pharmacies participating in the palliative care drugs service Longton Pharmacy (Facer) 66 Liverpool Road, Longton, PR4 5PB, 01772 613286 Kingsfold Pharmacy, 69 Pope Lane, Penwortham, Preston, PR1 9BY Lloyds Pharmacy. Library Street, Chorley, PR7 2EE. 01257 263628 Sainsbury s in store pharmacy. Cuerden Way, Bamber Bridge, Preston, PR5 6BJ 01772 627762 Rimmers Pharmacy 116-118 Wigan Road, Euxton, Chorley, PR7 6JW 01257 269862 Asda Pharmacy, East Road, Fulwood, Preston, PR2 9NP, 01772 703130 MX Pharmacy, 51-53 Longridge Road, Preston, PR2 6RE, 01772 654448 Lloyds Pharmacy, 112 Deepdale Road, Preston, PR1 5AR, 01772 254937 Palliative Care Drugs List Pack size Dexamethasone injection 4mg/ml (2ml ampoules) 5 Glycopyrronium bromide 200mcg/ml injection 3ml ampoules 12 Haloperidol 5mg/ml injection 1ml ampoules 5 Levomepromazine 25mg/ml injection 1ml ampoules 10 Midazolam 5mg/ml injection 2ml ampoule 30 Morphine Sulphate Injection 10mg/ml * 1ml ampoules 10 Morphine Sulphate Injection 30mg/ml* 1ml ampoules 10 Oramorph 10mg/5ml Solution 100ml Water for Injection 20ml ampoules 30

What is this leaflet about? Sometimes it can be difficult to get the medicines you might need in a hurry, especially at night or at weekends, so it is helpful to have them ready just in case. This leaflet explains why you have been given some just in case medication and how to look after it. Why have I been issued with the Just in case medication? The medicines you have been prescribed will help your District Nurse and/or GP to act quickly if you cannot take your usual tablets and develop symptoms such as pain or sickness. The medicines are ones that are effective when given into the skin by a small needle. Most people find this reassuring. With it there will be some information and prescription (sometimes called a SPAR booklet) for the nurse and doctors looking after you. The booklet tells them what to give you and when to give it. It also allows them to record when they have given you something. What are the Just in case medicines? There are a number of boxes containing ampoules of several different medications. These include: Morphine Sulphate to relieve pain Levomepromazine (Nozinan ) or Cyclizine (Valoid ) to relieve feeling or being sick Glycopyrronium (Robinul ) to relieve secretions in the chest Midazolam to relieve anxiety and restlessness Water to help give medicines to you. Who provides the Just in case medicines? Your GP or District Nurse will have authorised its use. They will review if you need its contents on a regular basis. The just in case medicines will come from a local pharmacy (chemist) who has been authorised to provide them, so it may not come from the pharmacy you usually use. They may come in a sealed bag, with your name and a list of the medicines it contains on the outside. Please do not try and open it. The bag will only be opened by the team caring for you if it is needed. Your caring team will check the medicines on a regular basis to make sure the medicines are accounted for. How do I look after my Just in case medicines? The medicines should be kept in a safe place out of the reach of children and pets. It does not need to be kept in the fridge but should be kept in a cool and dry place. Please make sure the nurses looking after you know where you have decided to keep the medicines. Should I stop the medicines I am taking at the moment? NO. The just in case drugs are not used to replace your usual medication, which you should continue to take as directed by your nurse or doctor. They can only be given to you by a nurse or a doctor. They should not be given to you by a relative or carer. Some people will never need the medications prescribed in this way. They are there just in case. They are only for use by you and should not be given to anyone else. What should I do with the Just in case medication when it is no longer needed? When the medicines are no longer needed they MUST be returned to a pharmacy for destruction. Where possible this should be the pharmacy who issued the medicines, (the name and address of the pharmacy concerned will be on the medicine s label). If the pharmacy that issued the bag is too far away or you are not sure which pharmacy it is, the medication can be returned to any pharmacy for destruction. As the just in case medication belongs to you it must be returned to the pharmacy by you or someone close to you. It cannot be returned to the pharmacy by a professional looking after you. They must not be disposed of with the household waste.

Useful telephone contact details ROLE NAME CONTACT NUMBER GP District Nurse Just in case medication Nurse Specialist Other local useful contacts out of hours Information leaflet for patients and carers